# New Animal Drugs for Use in Animal Feeds; Oxytetracycline Type A Medicated Articles
> **US Department of Health and Human Services** · Final rule. · Published 1996-10-03 · 61 FR 51588
## Document
- **Document number:** 96-25257
- **Category:** other
- **Sub-agency:** US Department of Health and Human Services
- **Federal Register citation:** 61 FR 51588
- **CFR reference:** 21 CFR 558
- **Publication date:** 1996-10-03
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides revised labeling for Pfizer's pioneer, Type A, oxytetracycline- containing, medicated articles which brings the products into compliance with the findings of the National Academy of Sciences/ National Research Council (NAS/NRC), Drug Efficacy Study Group's (DESI) effectiveness evaluation and subsequent FDA conclusions. In addition, the regulations are further amended to reflect approval, based on FDA's DESI ``me-too'' policy, of one original NADA each filed by Pfizer and PennField Oil Co. for Type A medicated articles that are copies of the Pfizer pioneer products.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1996/10/03/96-25257/new-animal-drugs-for-use-in-animal-feeds-oxytetracycline-type-a-medicated-articles)
---
*AI Analytics · CC0 1.0*